Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/128157
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Gratacós, Jordi |
dc.contributor.author | Pontes García, Caridad |
dc.contributor.author | Juanola, Xavier |
dc.contributor.author | Sanz, Jesús |
dc.contributor.author | Torres, Ferran |
dc.contributor.author | Avendaño, Cristina |
dc.contributor.author | Vallano Ferraz, Antonio |
dc.contributor.author | Calvo Rojas, Gonzalo |
dc.contributor.author | De Miguel, Eugenio |
dc.contributor.author | Sanmartí Sala, Raimon |
dc.contributor.author | REDES-TNF Investigators |
dc.date | 2019-02-12T11:23:51Z |
dc.date | 2019-02-12T11:23:51Z |
dc.date | 2019-01-08 |
dc.date | 2019-02-12T11:23:52Z |
dc.identifier.citation | 1478-6362 |
dc.identifier.citation | 684287 |
dc.identifier.uri | http://hdl.handle.net/2445/128157 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | BioMed Central |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1186/s13075-018-1772-z |
dc.relation | Arthritis Research & Therapy, 2019, vol. 21, p. 11 |
dc.relation | https://doi.org/10.1186/s13075-018-1772-z |
dc.rights | cc-by (c) Gratacós, Jordi et al., 2019 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Espondiloartropaties |
dc.subject | Administració de medicaments |
dc.subject | Posologia |
dc.subject | Citoquines |
dc.subject | Spondyloarthropathies |
dc.subject | Administration of drugs |
dc.subject | Posology |
dc.subject | Cytokines |
dc.title | Non-inferiority of dose reduction versusstandard dosing of TNF-inhibitors in axial spondyloarthritis |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |